{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:43:44Z","timestamp":1773409424076,"version":"3.50.1"},"reference-count":140,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2015.00047","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T14:46:23Z","timestamp":1424789183000},"source":"Crossref","is-referenced-by-count":9,"title":["Misfolded Proteins: From Little Villains to Little Helpers in the Fight Against Cancer"],"prefix":"10.3389","volume":"5","author":[{"given":"Ansgar","family":"Br\u00c3\u00bcning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"J\u00c3\u00bcckstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,2,24]]},"reference":[{"issue":"4096","key":"B1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.181.4096.223","article-title":"Principles that govern the folding of protein chains","volume":"181","author":"Anfinsen","year":"1973","journal-title":"Science"},{"issue":"1","key":"B2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.sbi.2004.01.009","article-title":"Theory of protein folding","volume":"14","author":"Onuchic","year":"2004","journal-title":"Curr Opin Struct Biol"},{"issue":"10","key":"B3","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/prot.24309","article-title":"Analyzing the effect of homogeneous frustration in protein folding","volume":"81","author":"Contessoto","year":"2013","journal-title":"Proteins"},{"issue":"45","key":"B4","doi-asserted-by":"publisher","first-page":"16623","DOI":"10.1073\/pnas.0606843103","article-title":"A backbone-based theory of protein folding","volume":"103","author":"Rose","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/10409230290771456","article-title":"The hydrophobic effect: a new insight from cold denaturation and a two-state water structure","volume":"37","author":"Tsai","year":"2002","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"14","key":"B6","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.febslet.2014.05.006","article-title":"Forces stabilizing proteins","volume":"588","author":"Pace","year":"2014","journal-title":"FEBS Lett"},{"issue":"1","key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.sbi.2010.10.008","article-title":"Folding at the birth of the nascent chain: coordinating translation with co-translational folding","volume":"21","author":"Zhang","year":"2011","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"B8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2014.03.007","article-title":"Differential scales of protein quality control","volume":"157","author":"Wolff","year":"2014","journal-title":"Cell"},{"issue":"6968","key":"B9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"issue":"6","key":"B10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1034\/j.1600-0854.2002.30602.x","article-title":"Hassles with taking out the garbage: aggravating aggresomes","volume":"3","author":"Garcia-Mata","year":"2002","journal-title":"Traffic"},{"issue":"6","key":"B11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nsmb.1592","article-title":"An expanding arsenal of experimental methods yields an explosion of insights into protein folding mechanisms","volume":"16","author":"Bartlett","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-biochem-060208-092442","article-title":"Molecular chaperone functions in protein folding and proteostasis","volume":"82","author":"Kim","year":"2013","journal-title":"Annu Rev Biochem"},{"issue":"6968","key":"B13","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nature02264","article-title":"Folding proteins in fatal ways","volume":"426","author":"Selkoe","year":"2003","journal-title":"Nature"},{"issue":"3","key":"B14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000103374","article-title":"How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases","volume":"74","author":"Aigelsreiter","year":"2007","journal-title":"Pathobiology"},{"issue":"11","key":"B15","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1016\/j.bbamcr.2013.03.007","article-title":"Orchestration of secretory protein folding by ER chaperones","volume":"1833","author":"Gidalevitz","year":"2013","journal-title":"Biochem Biophys Acta"},{"issue":"6","key":"B16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/carcin\/bgt111","article-title":"The HSP70 family and cancer","volume":"34","author":"Murphy","year":"2013","journal-title":"Carcinogenesis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1515\/BC.2006.064","article-title":"Protein aggregation in crowded environments","volume":"387","author":"Ellis","year":"2006","journal-title":"Biol Chem"},{"issue":"2","key":"B18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/02656730310001637334","article-title":"Role of nuclear protein denaturation and aggregation in thermal radiosensitization","volume":"20","author":"Lepock","year":"2004","journal-title":"Int J Hyperthermia"},{"issue":"12","key":"B19","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/pro.747","article-title":"The Levinthal paradox of the interactome","volume":"20","author":"Tompa","year":"2011","journal-title":"Protein Sci"},{"issue":"7","key":"B20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the hub of protein homeostasis: emerging mechanistic insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"B21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/1381612811306030347","article-title":"The therapeutic target Hsp90 and cancer hallmarks","volume":"19","author":"Miyata","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"9","key":"B22","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(13)70169-4","article-title":"Inhibition of HSP90 molecular chaperones: moving into the clinic","volume":"14","author":"Garcia-Carbonero","year":"2013","journal-title":"Lancet Oncol"},{"issue":"5","key":"B23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tibs.2013.02.003","article-title":"The chaperone Hsp90: changing partners for demanding clients","volume":"38","author":"R\u00c3\u00b6hl","year":"2013","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"B24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1517\/14728220902832697","article-title":"Inhibiting the transcription factor HSF1 as an anticancer strategy","volume":"13","author":"Whitesell","year":"2009","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"B25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbamcr.2011.10.008","article-title":"Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers","volume":"1823","author":"Jhaveri","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"B26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ctrv.2012.10.001","article-title":"Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions","volume":"39","author":"Hong","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"B27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.breast.2013.06.003","article-title":"Hsp90 inhibitors in breast cancer: a systematic review","volume":"22","author":"Zagouri","year":"2013","journal-title":"Breast"},{"key":"B28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.taap.2013.09.018","article-title":"A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors","volume":"273","author":"Zhou","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"B29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/2319-4170.113230","article-title":"Structure, function and regulation of the hsp90 machinery","volume":"36","author":"Li","year":"2013","journal-title":"Biomed J"},{"issue":"41","key":"B30","doi-asserted-by":"publisher","first-page":"38294","DOI":"10.1074\/jbc.M206566200","article-title":"The assembly and intermolecular properties of the hsp70-Hop-hsp90 molecular chaperone complex","volume":"277","author":"Hern\u00c3\u00a1ndez","year":"2002","journal-title":"J Biol Chem"},{"issue":"6","key":"B31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00018-004-4464-6","article-title":"Hsp70 chaperones: cellular functions and molecular mechanism","volume":"62","author":"Mayer","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"B32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.tcb.2012.05.006","article-title":"Chaperone-mediated autophagy: a unique way to enter the lysosome world","volume":"22","author":"Kaushik","year":"2012","journal-title":"Trends Cell Biol"},{"issue":"3","key":"B33","first-page":"286","article-title":"Integration of autophagy, proteasomal degradation, unfolded protein response and apoptosis","volume":"34","author":"Benbrook","year":"2012","journal-title":"Exp Oncol"},{"issue":"4","key":"B34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1379\/1466-1268(2003)0080303:CALBTC2.0.CO;2","article-title":"CHIP: a link between the chaperone and proteasome systems","volume":"8","author":"McDonough","year":"2003","journal-title":"Cell Stress Chaperones"},{"issue":"16","key":"B35","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1111\/j.1742-4658.2010.07737.x","article-title":"CHIP participates in protein triage decisions by preferentially ubiquitinating Hsp70-bound substrates","volume":"277","author":"Stankiewicz","year":"2010","journal-title":"FEBS J"},{"issue":"19","key":"B36","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.febslet.2007.05.039","article-title":"The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions","volume":"581","author":"Daugaard","year":"2007","journal-title":"FEBS Lett"},{"issue":"10","key":"B37","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.biocel.2012.06.012","article-title":"Transcriptional regulation of small HSP-HSF1 and beyond","volume":"44","author":"de Thonel","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1242\/jcs.01284","article-title":"\u00e2\u20ac\u02dcThe stress of dying\u00e2\u20ac\u2122: the role of heat shock proteins in the regulation of apoptosis","volume":"117","author":"Beere","year":"2004","journal-title":"J Cell Sci"},{"issue":"3","key":"B39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2012.06.031","article-title":"HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers","volume":"150","author":"Mendillo","year":"2012","journal-title":"Cell"},{"issue":"10","key":"B40","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2217\/fon.13.106","article-title":"HSF1-mediated regulation of tumor cell apoptosis: a novel target for cancer therapeutics","volume":"9","author":"Kumar","year":"2013","journal-title":"Future Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nrm2938","article-title":"Heat shock factors: integrators of cell stress, development and lifespan","volume":"11","author":"Akerfelt","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"B42","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.4161\/cc.9.8.11204","article-title":"Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?","volume":"9","author":"Powers","year":"2010","journal-title":"Cell Cycle"},{"issue":"7","key":"B43","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.bmcl.2013.02.014","article-title":"Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets","volume":"23","author":"McConnell","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"B44","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.18632\/oncotarget.1584","article-title":"Heat shock proteins in multiple myeloma","volume":"5","author":"Zhang","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"B45","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1128\/MCB.12.8.3490","article-title":"Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids","volume":"12","author":"Hosokawa","year":"1992","journal-title":"Mol Cell Biol"},{"key":"B46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/bj3000201","article-title":"Regulation of heat shock protein synthesis by quercetin in human erythroleukaemia cells","volume":"300","author":"Elia","year":"1994","journal-title":"Biochem J"},{"issue":"3","key":"B47","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1006\/bbrc.1995.1447","article-title":"Quercetin suppresses heat shock response by down regulation of HSF1","volume":"208","author":"Nagai","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/pros.20845","article-title":"The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90","volume":"68","author":"Aalinkeel","year":"2008","journal-title":"Prostate"},{"issue":"7","key":"B49","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2174\/18715206113139990114","article-title":"Inhibition of mTOR signaling by quercetin in cancer treatment and prevention","volume":"13","author":"Bruning","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"issue":"4","key":"B50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bjh.12164","article-title":"The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma","volume":"160","author":"Heimberger","year":"2013","journal-title":"Br J Haematol"},{"issue":"6","key":"B51","doi-asserted-by":"crossref","first-page":"816","DOI":"10.18632\/oncotarget.991","article-title":"Targeting HSF1 sensitizes cancer cells to HSP90 inhibition","volume":"4","author":"Chen","year":"2013","journal-title":"Oncotarget"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fonc.2012.00005","article-title":"K63-linked ubiquitination in kinase activation and cancer","volume":"2","author":"Wang","year":"2012","journal-title":"Front Oncol"},{"issue":"1","key":"B53","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/ERC-14-0005","article-title":"The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors","volume":"22","author":"Johnson","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"B54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbamcr.2013.07.007","article-title":"The complexity of recognition of ubiquitinated substrates by the 26S proteasome","volume":"1843","author":"Ciechanover","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"B55","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: a suitable antineoplastic target","volume":"4","author":"Adams","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"B56","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4161\/cc.9.3.11152","article-title":"Degradation of ubiquitin: the fate of the cellular reaper","volume":"9","author":"Shabek","year":"2010","journal-title":"Cell Cycle"},{"issue":"49","key":"B57","doi-asserted-by":"publisher","first-page":"33713","DOI":"10.1074\/jbc.R109.018481","article-title":"The 26 S proteasome: from basic mechanisms to drug targeting","volume":"284","author":"Navon","year":"2009","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fonc.2012.00015","article-title":"Regulation of ubiquitination-mediated protein degradation by survival kinases in cancer","volume":"2","author":"Yamaguchi","year":"2012","journal-title":"Front Oncol"},{"issue":"4","key":"B59","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.3747\/co.21.1798","article-title":"Bortezomib in multiple myeloma: systematic review and clinical considerations","volume":"21","author":"Kouroukis","year":"2014","journal-title":"Curr Oncol"},{"issue":"2","key":"B60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.critrevonc.2014.05.003","article-title":"Linking the activity of bortezomib in multiple myeloma and autoimmune diseases","volume":"92","author":"Skrott","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"B61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chembiol.2012.01.003","article-title":"Proteasome inhibitors: an expanding army attacking a unique target","volume":"19","author":"Kisselev","year":"2012","journal-title":"Chem Biol"},{"issue":"6","key":"B62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.blre.2013.10.002","article-title":"Targeting the ubiquitin proteasome system in haematological malignancies","volume":"27","author":"Crawford","year":"2013","journal-title":"Blood Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"issue":"6","key":"B64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10637-008-9206-4","article-title":"Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis","volume":"27","author":"Br\u00c3\u00bcning","year":"2009","journal-title":"Invest New Drugs"},{"issue":"6","key":"B65","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/jcmm.12279","article-title":"Proteasome inhibitors \u00e2\u20ac\u201c molecular basis and current perspectives in multiple myeloma","volume":"18","author":"Kubiczkova","year":"2014","journal-title":"J Cell Mol Med"},{"issue":"2","key":"B66","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ana.20935","article-title":"Failure of proteasome inhibitor administration to provide a model of Parkinson\u00e2\u20ac\u2122s disease in rats and monkeys","volume":"60","author":"Kordower","year":"2006","journal-title":"Ann Neurol"},{"issue":"8","key":"B67","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/jphp.12072","article-title":"Carfilzomib: a novel agent for multiple myeloma","volume":"65","author":"Redic","year":"2013","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"B68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1345\/aph.1R561","article-title":"Carfilzomib: a second-generation proteasome inhibitor for the treatment of relapsed and refractory multiple myeloma","volume":"47","author":"Thompson","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"1","key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2013.10.018","article-title":"New orally active proteasome inhibitors in multiple myeloma","volume":"38","author":"Allegra","year":"2014","journal-title":"Leuk Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"9706","DOI":"10.1021\/jf9017492","article-title":"Inhibitory effect of flavonoids on 26S proteasome activity","volume":"57","author":"Chang","year":"2009","journal-title":"J Agric Food Chem"},{"issue":"1","key":"B71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00418-011-0869-0","article-title":"Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity","volume":"137","author":"Klappan","year":"2012","journal-title":"Histochem Cell Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bcp.2011.08.010","article-title":"The flavonoid quercetin in disease prevention and therapy: facts and fancies","volume":"83","author":"Russo","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"B73","doi-asserted-by":"publisher","first-page":"206","DOI":"10.7497\/j.issn.2095-3941.2013.04.004","article-title":"Why bortezomib cannot go with \u00e2\u20ac\u02dcgreen\u00e2\u20ac\u2122?","volume":"10","author":"Jia","year":"2013","journal-title":"Cancer Biol Med"},{"issue":"9","key":"B74","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3109\/10428194.2012.760733","article-title":"Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia","volume":"54","author":"Walker","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B75","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2141.2011.08664.x","article-title":"Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1\/2 study","volume":"153","author":"Richardson","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"B76","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s10637-013-9946-7","article-title":"Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies","volume":"31","author":"Schenk","year":"2013","journal-title":"Invest New Drugs"},{"issue":"6","key":"B77","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/ijc.21534","article-title":"Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram","volume":"118","author":"L\u00c3\u00b6vborg","year":"2006","journal-title":"Int J Cancer"},{"issue":"21","key":"B78","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"B79","doi-asserted-by":"crossref","first-page":"502","DOI":"10.18632\/oncotarget.969","article-title":"A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the international initiative for accelerated improvement of glioblastoma care","volume":"4","author":"Kast","year":"2013","journal-title":"Oncotarget"},{"key":"B80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18632\/oncoscience.5","article-title":"Disulfiram\/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition","volume":"1","author":"Papaioannou","year":"2014","journal-title":"Oncoscience"},{"issue":"10","key":"B81","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.4161\/cc.28959","article-title":"Oxidizing to death: disulfiram for cancer cell killing","volume":"13","author":"Br\u00c3\u00bcning","year":"2014","journal-title":"Cell Cycle"},{"issue":"3","key":"B82","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/156800911794519798","article-title":"Disulfiram, and disulfiram derivatives as novel potential anticancer drugs targeting the ubiquitin-proteasome system in both preclinical and clinical studies","volume":"11","author":"Kona","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"issue":"12","key":"B83","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends Cell Biol"},{"issue":"6","key":"B84","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"issue":"4","key":"B85","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1074\/jbc.M111.273730","article-title":"Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini","volume":"287","author":"Ouyang","year":"2012","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1042\/BST0380144","article-title":"Parkin-mediated ubiquitin signalling in aggresome formation and autophagy","volume":"38","author":"Chin","year":"2010","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"B87","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.molcel.2013.08.016","article-title":"Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains","volume":"51","author":"Hao","year":"2013","journal-title":"Mol Cell"},{"issue":"5","key":"B88","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/emboj.2009.405","article-title":"HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J"},{"issue":"29","key":"B89","doi-asserted-by":"publisher","first-page":"26729","DOI":"10.1074\/jbc.C500186200","article-title":"Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors","volume":"280","author":"Bali","year":"2005","journal-title":"J Biol Chem"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e004","DOI":"10.1621\/nrs.03004","article-title":"Chaperoning steroid hormone signaling via reversible acetylation","volume":"3","author":"Kovacs","year":"2005","journal-title":"Nucl Recept Signal"},{"issue":"17","key":"B91","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Boyault","year":"2007","journal-title":"Genes Dev"},{"issue":"6864","key":"B92","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/414652a","article-title":"The AAA ATPase Cdc48\/p97 and its partners transport proteins from the ER into the cytosol","volume":"414","author":"Ye","year":"2001","journal-title":"Nature"},{"issue":"1","key":"B93","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbamcr.2011.07.001","article-title":"Recent advances in p97\/VCP\/Cdc48 cellular functions","volume":"1823","author":"Yamanaka","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"B94","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ncb2407","article-title":"Emerging functions of the VCP\/p97 AAA-ATPase in the ubiquitin system","volume":"14","author":"Meyer","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"14","key":"B95","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/sj.emboj.7601210","article-title":"HDAC6-p97\/VCP controlled polyubiquitin chain turnover","volume":"25","author":"Boyault","year":"2006","journal-title":"EMBO J"},{"key":"B96","doi-asserted-by":"publisher","first-page":"875824","DOI":"10.1155\/2011\/875824","article-title":"The role of HDAC6 in cancer","volume":"2011","author":"Aldana-Masangkay","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"7","key":"B97","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12094-008-0221-x","article-title":"Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer","volume":"10","author":"Mart\u00c3\u00adnez-Iglesias","year":"2008","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"B98","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/CAD.0000000000000040","article-title":"Histone deacetylase inhibitors: an overview of the clinical studies in solid tumors","volume":"25","author":"Slingerland","year":"2014","journal-title":"Anticancer Drugs"},{"issue":"8","key":"B99","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"B100","doi-asserted-by":"publisher","first-page":"8567","DOI":"10.1073\/pnas.0503221102","article-title":"Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma","volume":"102","author":"Hideshima","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"B101","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3109\/10428194.2011.570821","article-title":"Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells","volume":"52","author":"Aldana-Masangkay","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"46","key":"B102","doi-asserted-by":"publisher","first-page":"20003","DOI":"10.1073\/pnas.1013754107","article-title":"Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents","volume":"107","author":"Namdar","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"B103","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"4","key":"B104","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3233\/JAD-140066","article-title":"Tubastatin A\/ACY-1215 improves cognition in Alzheimer\u00e2\u20ac\u2122s disease transgenic mice","volume":"41","author":"Zhang","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"B105","doi-asserted-by":"publisher","first-page":"742","DOI":"10.4161\/cbt.28469","article-title":"Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells","volume":"15","author":"Rosik","year":"2014","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"B106","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1182\/blood-2011-10-387365","article-title":"Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma","volume":"119","author":"Santo","year":"2012","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nature06384","article-title":"Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes","volume":"450","author":"Rapoport","year":"2007","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-biochem-062209-093836","article-title":"Protein folding and modification in the mammalian endoplasmic reticulum","volume":"80","author":"Braakman","year":"2011","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"B109","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/0968768031000069241","article-title":"Protein folding and translocation across the endoplasmic reticulum membrane","volume":"20","author":"Swanton","year":"2003","journal-title":"Mol Membr Biol"},{"issue":"2","key":"B110","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molcel.2010.10.001","article-title":"Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms","volume":"40","author":"Buchberger","year":"2010","journal-title":"Mol Cell"},{"issue":"6059","key":"B111","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.1209235","article-title":"Road to ruin: targeting proteins for degradation in the endoplasmic reticulum","volume":"334","author":"Smith","year":"2011","journal-title":"Science"},{"issue":"9","key":"B112","doi-asserted-by":"publisher","first-page":"a013185","DOI":"10.1101\/cshperspect.a013185","article-title":"The mammalian endoplasmic reticulum-associated degradation system","volume":"5","author":"Olzmann","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"B113","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.cdd.4402279","article-title":"Fold up or perish: unfolded protein response and chemotherapy","volume":"15","author":"Strasser","year":"2008","journal-title":"Cell Death Differ"},{"issue":"1\u00e2\u20ac\u201c3","key":"B114","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejphar.2009.06.064","article-title":"Targeting the endoplasmic reticulum-stress response as an anticancer strategy","volume":"625","author":"Healy","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"B115","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pharmthera.2012.02.003","article-title":"Stress management at the ER: regulators of ER stress-induced apoptosis","volume":"134","author":"Gorman","year":"2012","journal-title":"Pharmacol Ther"},{"issue":"5","key":"B116","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bcp.2012.09.012","article-title":"Pharmacological targeting of endoplasmic reticulum stress signaling in cancer","volume":"85","author":"Sch\u00c3\u00b6nthal","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"182834","DOI":"10.1155\/2012\/182834","article-title":"Reticulophagy and ribophagy: regulated degradation of protein production factories","volume":"2012","author":"Cebollero","year":"2012","journal-title":"Int J Cell Biol"},{"issue":"3","key":"B118","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Tabas","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"12","key":"B119","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1016\/j.bbamcr.2013.06.028","article-title":"ER stress-induced cell death mechanisms","volume":"1833","author":"Sano","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"B120","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1016\/j.bbamcr.2013.07.024","article-title":"When ER stress reaches a dead end","volume":"1833","author":"Urra","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B121","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbrc.2009.05.148","article-title":"Lopinavir co-induces insulin resistance and ER stress in human adipocytes","volume":"386","author":"Djedaini","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B122","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.gastro.2009.08.054","article-title":"HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells","volume":"138","author":"Wu","year":"2010","journal-title":"Gastroenterology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.freeradbiomed.2013.08.161","article-title":"Comparative analysis of ER stress response into HIV protease inhibitors: lopinavir but not darunavir induces potent ER stress response via ROS\/JNK pathway","volume":"65","author":"Taura","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"B124","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1593\/neo.07124","article-title":"The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response","volume":"9","author":"Gupta","year":"2007","journal-title":"Neoplasia"},{"issue":"17","key":"B125","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1158\/1078-0432.CCR-07-0161","article-title":"Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo","volume":"13","author":"Gills","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"22","key":"B126","doi-asserted-by":"publisher","first-page":"10920","DOI":"10.1158\/0008-5472.CAN-07-0796","article-title":"HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress","volume":"67","author":"Pyrko","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"B127","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ygyno.2008.11.028","article-title":"The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells","volume":"112","author":"McLean","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"B128","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/1874-470211003020091","article-title":"New prospects for nelfinavir in non-HIV-related diseases","volume":"3","author":"Br\u00c3\u00bcning","year":"2010","journal-title":"Curr Mol Pharmacol"},{"issue":"7","key":"B129","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2174\/156800911796798913","article-title":"Bortezomib targets the caspase-like proteasome activity in cervical cancer cells, triggering apoptosis that can be enhanced by nelfinavir","volume":"11","author":"Br\u00c3\u00bcning","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"B130","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1091\/mbc.E03-07-0506","article-title":"Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin","volume":"15","author":"Fiebiger","year":"2004","journal-title":"Mol Biol Cell"},{"issue":"7","key":"B131","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1073\/pnas.0807611106","article-title":"ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"B132","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ygyno.2012.10.021","article-title":"Eeyarestatin causes cervical cancer cell sensitization to bortezomib treatment by augmenting ER stress and CHOP expression","volume":"128","author":"Brem","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"12","key":"B133","doi-asserted-by":"publisher","first-page":"e29073","DOI":"10.1371\/journal.pone.0029073","article-title":"Critical role of VCP\/p97 in the pathogenesis and progression of non-small cell lung carcinoma","volume":"6","author":"Valle","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"B134","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","article-title":"Hyperthermia in combined treatment of cancer","volume":"3","author":"Wust","year":"2002","journal-title":"Lancet Oncol"},{"issue":"17","key":"B135","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.ejca.2008.07.038","article-title":"Hyperthermia adds to chemotherapy","volume":"44","author":"Issels","year":"2008","journal-title":"Eur J Cancer"},{"issue":"1","key":"B136","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","author":"Hildebrandt","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"B137","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/02656730701769841","article-title":"Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events","volume":"24","author":"Roti Roti","year":"2008","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"B138","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/09553009014552221","article-title":"Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load","volume":"58","author":"Harmon","year":"1990","journal-title":"Int J Radiat Biol"},{"issue":"3","key":"B139","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/02656730902902001","article-title":"Activation of natural killer cells by heat shock protein 70","volume":"25","author":"Multhoff","year":"2009","journal-title":"Int J Hyperthermia"},{"issue":"18","key":"B140","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.18632\/oncotarget.2415","article-title":"A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors","volume":"5","author":"Blumenthal","year":"2014","journal-title":"Oncotarget"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T07:51:53Z","timestamp":1598773913000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fonc.2015.00047\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,24]]},"references-count":140,"URL":"https:\/\/doi.org\/10.3389\/fonc.2015.00047","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,24]]}}}